CN104027749A - Traditional Chinese medicine composition for treating chronic pelvic inflammation - Google Patents
Traditional Chinese medicine composition for treating chronic pelvic inflammation Download PDFInfo
- Publication number
- CN104027749A CN104027749A CN201410298484.2A CN201410298484A CN104027749A CN 104027749 A CN104027749 A CN 104027749A CN 201410298484 A CN201410298484 A CN 201410298484A CN 104027749 A CN104027749 A CN 104027749A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- rhizoma
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a traditional Chinese medicine composition for treating chronic pelvic inflammation. Selected material medicines are as follows in parts by weight: 10-20 parts of patrinia, 10-20 parts of oldenlandia diffusa, 5-10 parts of yellowish sophora roots, 5-10 parts of caulis sargentodoxae, 5-10 parts of corydalis tuber, 8-12 parts of cyperus rotundus, 8-15 parts of peach kernel, 10-20 parts of curcuma zedoary, 8-12 parts of dried tangerine or orange peel, 10-20 parts of rhizoma corydalis, 8-12 parts of endothelium corneum gigeriae galli and 5-10 parts of leonurus. The selected medicine materials achieve effects of clearing away heat and toxic materials, promoting blood circulation to remove blood stasis, relieving swelling and pain, soothing liver and regulating qi, relieving hard mass and inducing diuresis, invigorating spleen and supplementing qi, and the like. According to clinical application, the traditional Chinese medicine composition disclosed by the invention has the advantages of being quick to become effective, good in pesticide effect, low in cost, and free of toxic and side effects for treating chronic pelvic inflammation.
Description
Technical field
The invention belongs to the field of Chinese medicines, specifically a kind of Chinese medicine composition that can treat chronic pelvic inflammatory disease.
Background technology
Chronic pelvic inflammatory disease refers to female internal genital organs and around connective tissue, pelvic peritoneal chronic inflammatory disease.Mostly because thoroughly treatment of acute pelvic inflammatory disease adds that patient's body constitution is poor, resistance is not enough, due to delay and repeatedly outbreak; But also can be without acute pelvic inflammatory disease disease medical history process, as salpingitis due to chlamydia trachomatis infection.
Undergoing chronic pelvic inflammation symptom is: low grade fever, susceptible fatigue, insomnia, lassitude, whole body discomfort, hypogastric region falling inflation, pain and lumbosacral region are ached, aggravation after the fatigue of being everlasting, sexual intercourse, before and after menstruation.Menoxenia, fallopian tube adhesion also can cause infertile while blocking, bring very large impact to patient's body and mind.
At present, chronic pelvic inflammatory disease adopts anti-inflammation drugs to treat mostly, but because of the long-term inflammatory stimulus of patient, causes pelvic organ surrounding tissue to thicken adhesion, and anti-inflammatory drug is difficult for effectively, therefore the state of an illness is obstinate, outbreak repeatedly, causes patient's body constitution day empty, recovers slowly.Therefore, can invent to the ill a kind of Chinese medicine and treat according to the principle of the traditional Chinese medical science " treating both the principal and secondary aspects of a disease ", reach the shortening course of disease, prevent the object of chronic disease recurrence.
Summary of the invention
The invention solves at present in the defect existing aspect treatment chronic pelvic inflammatory disease, a kind of instant effect, short treating period, Chinese medicine composition cheap and without any side effects are provided.
The technical solution adopted in the present invention is: a kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease, it is characterized in that, and described compositions is comprised of the Chinese herb of following weight portion:
Herba Patriniae 10-20 part, Herba Hedyotidis Diffusae 10-20 part, radix sophorae 5-10 part, Caulis Sargentodoxae 5-10 part, Rhizoma Corydalis 5-10 part, Rhizoma Cyperi 8-12 part, Semen Persicae 8-15 part, Rhizoma Curcumae 10-20 part, Pericarpium Citri Reticulatae 8-12 part, Rhizoma Corydalis 10-20 part, Endothelium Corneum Gigeriae Galli 8-12 part, Herba Leonuri 5-10 part.
As this kind of prioritization scheme:
Described compositions is comprised of the Chinese herb of following weight portion:
10 parts of Herba Patriniae, 10 parts of Herba Hedyotidis Diffusaes, 5 parts of radix sophoraes, 5 parts of Caulis Sargentodoxaes, 5 parts of Rhizoma Corydalis, 8 parts of Rhizoma Cyperi, 8 parts, Semen Persicae, 10 parts of Rhizoma Curcumae, 8 parts of Pericarpium Citri Reticulataes, 10 parts of Rhizoma Corydalis, 8 parts of Endothelium Corneum Gigeriae Galli, 5 parts of Herba Leonuris.
As this kind of prioritization scheme:
Described compositions is comprised of the Chinese herb of following weight portion:
15 parts of Herba Patriniae, 15 parts of Herba Hedyotidis Diffusaes, 8 parts of radix sophoraes, 8 parts of Caulis Sargentodoxaes, 8 parts of Rhizoma Corydalis, 10 parts of Rhizoma Cyperi, 11 parts, Semen Persicae, 15 parts of Rhizoma Curcumae, 10 parts of Pericarpium Citri Reticulataes, 15 parts of Rhizoma Corydalis, 10 parts of Endothelium Corneum Gigeriae Galli, 8 parts of Herba Leonuris.
As this kind of prioritization scheme:
Described compositions is comprised of the Chinese herb of following weight portion:
20 parts of Herba Patriniae, 20 parts of Herba Hedyotidis Diffusaes, 10 parts of radix sophoraes, 10 parts of Caulis Sargentodoxaes, 10 parts of Rhizoma Corydalis, 12 parts of Rhizoma Cyperi, 15 parts, Semen Persicae, 20 parts of Rhizoma Curcumae, 12 parts of Pericarpium Citri Reticulataes, 20 parts of Rhizoma Corydalis, 12 parts of Endothelium Corneum Gigeriae Galli, 10 parts of Herba Leonuris.
The instructions of taking of above-mentioned Chinese medicine composition is: after the raw material Chinese medicine of above-mentioned weight proportion is mixed, according to the method for the fried Chinese medicine of tradition, get 500 milliliters of left and right of its medicine juice, 1 dose of every day, minute 2 clothes, seven days are a course for the treatment of.
The raw material Chinese medicine of above-mentioned Chinese medicine composition:
Herba Patriniae, cold nature, acrid in the mouth, hardship; Return stomach warp, large intestine channel, Liver Channel.There is heat-clearing and toxic substances removing, the effect of activating blood circulation to dissipate blood stasis.
Herba Hedyotidis Diffusae, bitter in the mouth, sweet, cold in nature; GUIXIN, liver, spleen, large intestine channel.There is heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation, the effect of promoting urination to remove dampness.
Radix sophorae, cold in nature, bitter in the mouth; Enter heart channel, Liver Channel, stomach warp, large intestine channel, urinary bladder channel.There is heat clearing and damp drying, the effect of spleen invigorating diuresis.
Caulis Sargentodoxae, bitter in the mouth is flat.Return large intestine channel.There is heat-clearing and toxic substances removing, the effect of promoting blood circulation and stopping pain.
Rhizoma Corydalis, warm in nature, acrid in the mouth, hardship; Enter heart channel, Liver Channel, spleen channel.There is blood circulation promoting and blood stasis dispelling, the effect of promoting the circulation of QI to relieve pain.
Rhizoma Cyperi, sweet in the mouth, is slightly cold; There is the resolving depression of regulating the flow of vital energy, the effect of pain relieving regulating menstruation.
Semen Persicae, nature and flavor are sweet flat, hardship; Return lung, liver, large intestine channel.There is blood circulation promoting and blood stasis dispelling, moisturize the effect of laxation.
Rhizoma Curcumae, acrid in the mouth, hardship; Return liver, spleen channel.There is removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving, the effect of expelling wind and removing dampness.
Pericarpium Citri Reticulatae, acrid in the mouth, hardship, warm in nature; Return spleen, stomach, lung meridian.There is regulating the flow of Qi and the middle Jiao, drying dampness to eliminate phlegm, the effect of diuretic relieving constipation.
Rhizoma Corydalis, acrid in the mouth, hardship, warm in nature; Return liver, spleen channel.There is regulating QI to relieve pain, the effect of promoting blood circulation to remove blood stasis.
Endothelium Corneum Gigeriae Galli, sweet in the mouth is flat; Return spleen, stomach, small intestinal, urinary bladder channel.Have invigorating the stomach and promoting digestion, controlling nocturnal emission with astringent drugs is the effect of something lost only.
Herba Leonuri, nature and flavor are bitter, pungent, are slightly cold; Return liver, pericardium channel.There is promoting blood flow to regulate menstruation, the effect of inducing diuresis to remove edema.
Chronic pelvic inflammatory disease is mainly that damp is taken advantage of a weak point due to deficiency of qi and blood, and damp invasion of lower energizer causes, the very difficult radical cure of general medicine.The traditional Chinese medical science is thought " qi being the governor of blood, blood being the material foundation of QI ", and the long-term virtual loss of QI and blood causes the main cause of pelvic inflammatory disease.Therefore when treatment, take blood circulation promoting and enriching, regulating YIN and YANG is main method.
Chinese medicine composition of the present invention, Herba Patriniae, Herba Hedyotidis Diffusae, Caulis Sargentodoxae all can heat-clearing and toxic substances removing, also can activating blood circulation to dissipate blood stasis; Radix sophorae, Pericarpium Citri Reticulatae can, heat clearing and damp drying, regulating the flow of Qi and the middle Jiao, spleen invigorating diuresis; Rhizoma Corydalis, Semen Persicae, Rhizoma Corydalis can promoting flow of QI and blood, and removing blood stasis to promote tissue regeneration is lived; Rhizoma Cyperi, Herba Leonuri can promoting blood flow to regulate menstruation, the resolving depression of regulating the flow of vital energy; Rhizoma Curcumae can removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving; Endothelium Corneum Gigeriae Galli can invigorating the stomach and promoting digestion, the effect of nourishing kidney qi.All medicines are played heat-clearing and toxic substances removing altogether, removing heat from blood antiinflammatory, and promoting flow of QI and blood, hard masses softening and resolving, the effects such as removing blood stasis to promote tissue regeneration, can eliminate the double conditioning health preserving again of main disease, eliminate the disease of hiding, and improve local microcirculation, maintain the comprehensive functions such as human normal physiological metabolism.
For further investigating the clinical efficacy of medicine of the present invention, we have selected 160 routine out-patients to carry out clinical trial, and patient is equal chronic pelvic inflammatory disease after diagnosing.Patient is divided into each 80 examples for the treatment of group and matched group at random, and wherein the treatment group age is 20-52 year, course of disease March-4 year, and the matched group age is 21-50 year, course of disease March-3.5 year; In gynecologial examination, 36 cases with uterine limitation of activity, tenderness; The streak tenderness of 73 routine fallopian tube; 28 cases with uterine one or both sides lamellars thicken, tenderness; Inflammatory mass in 23 routine pelvic cavity, non-tumor.
Criterion of therapeutical effect:
Recovery from illness: clinical symptom disappearance, it is normal that gynecologial examination recovers.
Effective: clinical symptoms obviously alleviates, gynecologial examination has clear improvement.
Take a turn for the better: clinical symptom relief, gynecologial examination makes moderate progress.
Invalid: clinical symptoms and sign are without change.
Therapeutic Method:
Treatment group is taken the Chinese medicine composition of embodiment 2, according to the method for the fried Chinese medicine of tradition, gets its medicine juice, and 1 dose of every day, minute 2 clothes, seven days are a course for the treatment of, and stop using menstrual period.Matched group carries out conventional anti-infective therapy.
Curative effect comparision after two groups of case treatments the results are shown in Table one.
After treatment two weeks, treatment group 31 examples of fully recovering, effective 28 examples, 20 examples that take a turn for the better, invalid 1 example, total effective rate reaches 96.3%; Matched group 22 examples of fully recovering, effective 20 examples, 27 examples that take a turn for the better, invalid 11 examples, total effective rate reaches 86.3%;
Table one: the curative effect comparision result table after two groups of case treatments
| Group | Number of cases | Recovery from illness n (%) | Effective n (%) | Improvement n (%) | Invalid n (%) | Total effective rate (%) |
| Matched group | 80 | 31(38.8) | 28(35.0) | 20(25.0) | 1(1.25) | 98.75 |
| Treatment group | 80 | 22(27.5) | 20(25.0) | 27(33.8) | 11(13.8) | 86.3 |
In table one, result shows, Chinese medicine composition of the present invention is evident in efficacy to chronic pelvic inflammatory disease, clinic promotion and application.
The specific embodiment
Embodiment 1: a kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease, choose 10 parts of Herba Patriniae, 10 parts of Herba Hedyotidis Diffusaes, 5 parts of radix sophoraes, 5 parts of Caulis Sargentodoxaes, 5 parts of Rhizoma Corydalis, 8 parts of Rhizoma Cyperi, 8 parts, Semen Persicae, 10 parts of Rhizoma Curcumae, 8 parts of Pericarpium Citri Reticulataes, 10 parts of Rhizoma Corydalis, 8 parts of Endothelium Corneum Gigeriae Galli, 5 parts of Herba Leonuris.
Embodiment 2: a kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease, choose 15 parts of Herba Patriniae, 15 parts of Herba Hedyotidis Diffusaes, 8 parts of radix sophoraes, 8 parts of Caulis Sargentodoxaes, 8 parts of Rhizoma Corydalis, 10 parts of Rhizoma Cyperi, 11 parts, Semen Persicae, 15 parts of Rhizoma Curcumae, 10 parts of Pericarpium Citri Reticulataes, 15 parts of Rhizoma Corydalis, 10 parts of Endothelium Corneum Gigeriae Galli, 8 parts of Herba Leonuris.
Embodiment 3: a kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease, choose 20 parts of Herba Patriniae, 20 parts of Herba Hedyotidis Diffusaes, 10 parts of radix sophoraes, 10 parts of Caulis Sargentodoxaes, 10 parts of Rhizoma Corydalis, 12 parts of Rhizoma Cyperi, 15 parts, Semen Persicae, 20 parts of Rhizoma Curcumae, 12 parts of Pericarpium Citri Reticulataes, 20 parts of Rhizoma Corydalis, 12 parts of Endothelium Corneum Gigeriae Galli, 10 parts of Herba Leonuris.
" every part " i.e. " every gram " in above embodiment.
Below by concrete case, Chinese medicine composition curative effect of the present invention is further verified:
Case 1
Wang, 34 years old, lower abdominal distention pain tenderness after patient had sexual intercourse before 1 day, leukorrhagia amount is few, and color is slightly yellow, constipation, light red tongue white and thin fur is greasy, slippery and rapid pulse.At the bottom of gynecologial examination palace and bilateral attachment area tenderness is chronic pelvic inflammatory disease after diagnosing.Take Chinese medicine composition of the present invention after the course for the treatment of, all diseases are clearly better, and after two courses for the treatment of, patient's lower abdominal distention pain is healed, and leukorrhagia color is slightly yellow, occasionally has the soreness of waist, and defecation is still adjusted, and light red tongue white and thin fur is greasy, thready pulse.After with disease plus-minus after treatment two weeks, patient's recovery from illness, follows up a case by regular visits to after 1 year without recurrence.
Case 2
Lee, 32 years old, patient was before 2 years once after fatigue, there is first lower abdomen pain, companion's soreness of waist pain, leucorrhea amount is many, yellow skin has taste, through hospital, ultrasound diagnosis is diagnosed as pelvic inflammatory disease, alleviates, but recur again less than first quarter moon with antibiotic therapy, the continuation antibiotic of having to, so again and again nearly 2 years, nowadays to no effect, patient was also afraid of to use for a long time antibiotic adverse consequences to antibiotic.After being introduced, take Chinese medicine composition of the present invention, after the course for the treatment of, patient body symptom is obviously improved, and after two courses for the treatment of, symptom subtracts greatly, and health is almost recovered, and follows up a case by regular visits to without recurrence after half a year.
Case 3
Cai, 42 years old, before patient 3 years, because once drenching with rain and occur lower abdominal pain symptom, while clear and thin leucorrhea, amount is many, when hospital admission, be diagnosed as pelvic inflammatory disease, and infusion treatment is able to respite, after this usually irregularly outbreak, cold extremities with aversion to cold at ordinary times, the easy weak soreness of waist, time and frequent micturition, menstruation color is dark, there is clot, existing cold and pain in the lower abdomen, obtain warm alleviation of pain, clear and thin leucorrhea is tasteless, amount is a lot, light red tongue, deep pulse is unable, take continuously Chinese medicine composition of the present invention after two courses for the treatment of, the all disease seats of health are known and are subtracted, continue to take after the course for the treatment of, recovery from illness, after half a year, follow up a case by regular visits to without recurrence.
Case 4
Zhao, 39 years old, patient was because causing Right Lower Abdomen pain puerperal before 2 years, and fatigue increases the weight of, and often pain in the lumbar region, does not like drink.Leucorrhea is many, and yellowish have a taste.Deep-thready pulse, greasy and thin fur is yellowish, through examining as chronic pelvic inflammatory disease.Take Chinese medicine composition of the present invention after the course for the treatment of, lower abdomen pain relief, leucorrhea amount is few; Connect after the course for the treatment of, leucorrhea is normal, and stomachache disappears, and clinical cure is followed up a case by regular visits to after 1 year without recurrence.
Claims (4)
1. a Chinese medicine composition for the treatment of chronic pelvic inflammatory disease, is characterized in that, described compositions is comprised of the Chinese herb of following weight portion:
Herba Patriniae 10-20 part, Herba Hedyotidis Diffusae 10-20 part, radix sophorae 5-10 part, Caulis Sargentodoxae 5-10 part, Rhizoma Corydalis 5-10 part, Rhizoma Cyperi 8-12 part, Semen Persicae 8-15 part, Rhizoma Curcumae 10-20 part, Pericarpium Citri Reticulatae 8-12 part, Rhizoma Corydalis 10-20 part, Endothelium Corneum Gigeriae Galli 8-12 part, Herba Leonuri 5-10 part.
2. Chinese medicine composition according to claim 1, is characterized in that, described Chinese medicine composition is comprised of the Chinese herb of following weight portion:
10 parts of Herba Patriniae, 10 parts of Herba Hedyotidis Diffusaes, 5 parts of radix sophoraes, 5 parts of Caulis Sargentodoxaes, 5 parts of Rhizoma Corydalis, 8 parts of Rhizoma Cyperi, 8 parts, Semen Persicae, 10 parts of Rhizoma Curcumae, 8 parts of Pericarpium Citri Reticulataes, 10 parts of Rhizoma Corydalis, 8 parts of Endothelium Corneum Gigeriae Galli, 5 parts of Herba Leonuris.
3. Chinese medicine composition according to claim 1, is characterized in that, described Chinese medicine composition is comprised of the Chinese herb of following weight portion:
15 parts of Herba Patriniae, 15 parts of Herba Hedyotidis Diffusaes, 8 parts of radix sophoraes, 8 parts of Caulis Sargentodoxaes, 8 parts of Rhizoma Corydalis, 10 parts of Rhizoma Cyperi, 11 parts, Semen Persicae, 15 parts of Rhizoma Curcumae, 10 parts of Pericarpium Citri Reticulataes, 15 parts of Rhizoma Corydalis, 10 parts of Endothelium Corneum Gigeriae Galli, 8 parts of Herba Leonuris.
4. Chinese medicine composition according to claim 1, is characterized in that, described Chinese medicine composition is comprised of the Chinese herb of following weight portion:
20 parts of Herba Patriniae, 20 parts of Herba Hedyotidis Diffusaes, 10 parts of radix sophoraes, 10 parts of Caulis Sargentodoxaes, 10 parts of Rhizoma Corydalis, 12 parts of Rhizoma Cyperi, 15 parts, Semen Persicae, 20 parts of Rhizoma Curcumae, 12 parts of Pericarpium Citri Reticulataes, 20 parts of Rhizoma Corydalis, 12 parts of Endothelium Corneum Gigeriae Galli, 10 parts of Herba Leonuris.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410298484.2A CN104027749A (en) | 2014-06-19 | 2014-06-19 | Traditional Chinese medicine composition for treating chronic pelvic inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410298484.2A CN104027749A (en) | 2014-06-19 | 2014-06-19 | Traditional Chinese medicine composition for treating chronic pelvic inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104027749A true CN104027749A (en) | 2014-09-10 |
Family
ID=51458893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410298484.2A Pending CN104027749A (en) | 2014-06-19 | 2014-06-19 | Traditional Chinese medicine composition for treating chronic pelvic inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104027749A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1188442A2 (en) * | 2000-09-13 | 2002-03-20 | Wei Xiao | Cinnamomi and poria composition, method to prepare the same and uses thereof |
| CN101085271A (en) * | 2007-06-29 | 2007-12-12 | 李永红 | Oral administration traditional Chinese medicine composition for curing chronic pelvic inflammatory disease |
| CN102988876A (en) * | 2011-09-16 | 2013-03-27 | 律北平 | Traditional Chinese medicine formulation for treating pelvic inflammatory masses |
-
2014
- 2014-06-19 CN CN201410298484.2A patent/CN104027749A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1188442A2 (en) * | 2000-09-13 | 2002-03-20 | Wei Xiao | Cinnamomi and poria composition, method to prepare the same and uses thereof |
| CN101085271A (en) * | 2007-06-29 | 2007-12-12 | 李永红 | Oral administration traditional Chinese medicine composition for curing chronic pelvic inflammatory disease |
| CN102988876A (en) * | 2011-09-16 | 2013-03-27 | 律北平 | Traditional Chinese medicine formulation for treating pelvic inflammatory masses |
Non-Patent Citations (2)
| Title |
|---|
| 吴中兰等: "自拟消疒徵化瘀汤治疗附件炎性包块30例", 《国医论坛》 * |
| 王蓓等: "中药治疗慢性盆腔炎48例", 《中国民间疗法》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100493598C (en) | Oral Chinese traditional medicine composition for treating chronic enteritis | |
| CN103908628B (en) | A kind of herbal enema medicament treating chronic pelvic inflammatory disease and preparation method thereof | |
| CN104189871A (en) | Medicated wine for treating osteoproliferation | |
| CN102188685B (en) | Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof | |
| CN100579562C (en) | Oral Chinese medicine composition for treating constipation | |
| CN104258304A (en) | Medicated wine for meridian unblocking, wind dispelling, collaterals activating and pain relieving | |
| CN101983644A (en) | Medicament for treating sequelae of apoplexy | |
| CN103977113B (en) | A kind of Chinese medicine for the treatment of diabetic foot | |
| CN103768358B (en) | A kind of Chinese medicine composition for the treatment of chronic prostatitis | |
| CN102872300B (en) | Traditional Chinese medicine for treating non-gonococcal urethritis | |
| CN104940484A (en) | Traditional Chinese medicine for treating gout | |
| CN104383479A (en) | Traditional Chinese medicine foot bath composition for treating varicosity and preparation method of traditional Chinese medicine foot bath composition | |
| CN101371900A (en) | Orally taken Chinese medicinal composition for treating constipation | |
| CN103211911A (en) | Medicine for treating thromboangiitis obliterans | |
| CN104623532A (en) | Traditional Chinese medicine composition for treating glioma and preparation method thereof | |
| CN104117002A (en) | Traditional Chinese medicinal preparation for treating intractable constipation | |
| CN104056053A (en) | Traditional Chinese medicine preparation for treating non-purulent costal chondritis | |
| CN104225569A (en) | Chinese medicinal composition for treating chronic enteritis | |
| CN104027749A (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammation | |
| CN108042744A (en) | A kind of Chinese medicine composition and preparation method for being used to treat prostatic disorders | |
| CN102240384B (en) | Medicament for treating phlegm-stasis accumulating type epilepsy and preparation method thereof | |
| CN104127814A (en) | Traditional Chinese medicinal preparation for curing pelvic inflammation | |
| CN105169186A (en) | Traditional Chinese medicine preparation for treating constipation | |
| CN103127352B (en) | Chinese medicine composition for treating blood stasis type irregular menstruation | |
| CN103800621A (en) | Traditional Chinese medicine composition for treating prostatic hyperplasia and prostatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140910 |
|
| RJ01 | Rejection of invention patent application after publication |